Moderna Pauses Acrimonious Bid for Patent on mRNA Sequence, Says More Time is Needed for Discussions with NIH

Amid an ongoing dispute with the National Institutes of Health (NIH) over who exactly invented the mRNA sequence of Moderna’s COVID-19 vaccine, the company is hitting the pause button on pursuing a patent for the sequence.
Source: Drug Industry Daily